Alfred Phillips, DPM
Foot & Ankle Surgery · Hyannis, MANPI 1982727129
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $5,573 of the $8,655 with a category attached, or 64.4%. It is spread thinly across 43 manufacturers, the largest accounting for just 23.3%. Reporting peaked in 2021 at $2,518 and has fallen 73.4% since, to $670 in 2025.
Across 140 payments — averaging $61.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Treace Medical Concepts, Inc.$2K
- Kairos Surgical Inc$1K
- Stryker$952
- Smith+Nephew$628
- Integra Lifesciences Corporation$530
- Medartis Inc.$461
- plus $3K from 37 others
What the payments were for
- Travel & lodging$1,75720%
- Food & beverage$5,57364%
- Education$1,32515%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Lapiplasty System$1,594
- LAPIPLASTY SYSTEM 1$383
- HOFFMANN$276
- CITREFIX$171
- SALVATION$142
- TENOGLIDE TENDON PROTECTOR SHEET$138
- NEURAGEN NERVE GUIDE$138
- APTUS$125
- PuraPly$121
- GRAVITY$118
- PICO 7$118
- RENASYS TOUCH$118
- PRIME SERIES$113
- Stravix$113
- Grafix$113
- GrafixPL$113
- CERAMENTBONE VOID FILLER$111
- CERAMENT G$111
- Diamondback Peripheral$106
How this compares
$8,655 in reported general payments places this provider in the 85th percentile of 122 foot & ankle surgery providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ketoconazole | 18 | $357 |
| Cephalexin | 33 | $221 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 18 | $212 |
| Doxycycline Hyclate | 19 | $132 |
| Gabapentin | 23 | $99 |
| Oxycodone Hcl | 27 | $85 |
| Tramadol Hcl | 14 | $16 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Hyannis
- Richard BakerHyannis$16K
- Lauren WolffHyannis$5K
- Harry SchneiderCambridge$174K
- Craig LareauSpringfield$115K
- David SipalaBrighton$94K
- Philip BasileCambridge$90K
- Michael SgangaNatick$90K
- Joseph FleckNorth Chelmsford$35K
- Michael SkoniecznyPlymouth$33K
- Mark SlovenkaiWaltham$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.